PEDIATRICS Vol. 56 No. 5s November 1975, pp. 955-956
This Article
Right arrow Full Text (PDF)
Right arrow This Policy is No Longer Valid.
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yaffe, S. J.
Right arrow Articles by Simopoulos, A. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Yaffe, S. J.
Right arrow Articles by Simopoulos, A. P.

The Athlete and Medication

Committee on Drugs

Sumner J. Yaffe M.D., C. Warren Bierman M.D., Howard M. Cann M.D., Arnold P. Gold M.D., Frederic M. Kenny M.D., Harris D. Riley Jr. M.D., Irwin Schafer M.D., Lester F. Soyka M.D., Leo Stern M.D., Charles F. Weiss M.D., Gregory Chudzik Pharm.D., Harry C. Shirkey M.D., John C. Ballin Ph.D., Alan K. Done M.D., Louis Farchione M.D., C. P. Scott M.D., Jean D. Lockhart M.D., Steven Sawchuk M.D., and Artemis P. Simopoulos M.D.

The Committee on Drugs unites with the Joint Committee on Physical Fitness, Recreation, and Sports Medicine in condemning the use of drugs to improve athletic performance, However, the Committee on Drugs would like to clearly distinguish between the promiscuous use of drugs and their pharmacologic use to control a specific disease state enabling the adolescent to participate in sports, for example, the use of insulin for diabetes, anticonvulsants for epilepsy, digitalis for heart disease, or bronchodilators for asthma.

Children and adolescents with handicaps should be given the same advantages as other children, including participation in athletic activities. Athletes with medical conditions controlled by drugs should not be placed in the same category as youths taking drugs for other purposes, and there should be minimal, if any, restrictions imposed on them. One recent example of the type of restrictions which should not be imposed is the athlete with exercise-induced bronchoconstriction who was disqualified in the 1972 Olympics in Munich because he used a bronchodilator prescribed by his physician. Exercise-induced bronchospasm is a common handicap of allergic youth, and may occur in between 60% and 80% of individuals with allergic respiratory distress.1 Such bronchoconstriction can be modified by the administration of theopylline, theophylline epherdrine combinations,3 or cromolyn sodium,4, 5 The Committee on Children with Handicaps also recommends that children with asthma participate in sports and physical education and that every effort be made to minimize restrictions.6

At the annual meeting of the American Academy of Allergy in Washington, D.C., February 14, 1973, the following resolution was approved unanimously: "Participants in competitive athletics with asthma and other allergic conditions should not be disqualified because of the use, with medical supervision, of therapeutic doses of ephednine before and during athletic competition."7


The following policy statement has been revised:

THE ATHLETE AND MEDICATION
, , , , , , , , , , , , , , , , , , and
Pediatrics 52: 886-887.